C18H20FN3O5
Neat
377.37
Ofloxacin N-oxide, (R)-; 117678-37-2; UNII-AC9N7ZX6C3; AC9N7ZX6C3; (2R)-7-fluoro-2-methyl-6-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05, 13]trideca-5(13), 6, 8, 11-tetraene-11-carboxylic acid; 4-((3R)-6-Carboxy-9-fluoro-3-methyl-7-oxo-2, 3-dihydro-7H-pyrido(1, 2, 3-de)-1, 4-benzoxazin-10-yl)-1-methylpiperazine 1-oxide; 7H-Pyrido(1, 2, 3-de)-1, 4-benzoxazine-6-carboxylic acid, 9-fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-, (3R)-; 7H-Pyrido[1, 2, 3-de]-1, 4-benzoxazine-6-carboxylic acid, 9-fluoro-2, 3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, N-oxide, (R)-; (R)-ofloxacin N-oxide; (R)-Levofloxacin N-Oxide; A1-01732; Q27273863; (R)-4-(6-Carboxy-9-fluoro-3-methyl-7-oxo-2, 3-dihydro-7H-[1, 4]oxazino[2, 3 and 4-ij]quinolin-10-yl)-1-methylpiperazine 1-oxide
(2R)-7-fluoro-2-methyl-6-(4-methyl-4-oxidopiperazin-4-ium-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05, 13]trideca-5(13), 6, 8 and 11-tetraene-11-carboxylic acid
InChI=1S/C18H20FN3O5/c1-10-9-27-17-14-11(16(23)12(18(24)25)8-21(10)14)7-13(19)15(17)20-3-5-22(2,26)6-4-20/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m1/s1